Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| University of Arizona Medical School Graduate Medical Educational Costs | Contract | 482,861.00 | Other Sponsored Activity | Conrad Clemens | COM Academic Affairs | Veterans Administration - Ancillary Teaching | 07/2024 |
| VA IPA for Dan Griffiths (VA PI: Jonathan Lifshitz, PhD) | Grant | 115,542.00 | Research | Jonathan Lifshitz | COM Phx Psychiatry | United States Department of Veterans Affairs | 07/2024 |
| A Multi-Center Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products | Contract | * | Clinical Trial | Joshua Hustedt | COM Phx Orthopedics | Arthrex, Incorporated | 06/2024 |
| A Phase 1/2 Dose Escalation and Dose Expansion Study of ZNc3 in Combination with Niraparib in Subjects with Platinum Resistant Ovarian Cancer | Contract | * | Clinical Trial | Setsuko Chambers | Cancer Center Division | GOG Foundation, Inc. | 06/2024 |
| A Phase 1/2 Open-Label, Multicenter, Global Trial to Characterize the Safety, Tolerability and Preliminary Efficacy of CFT1946 as a Monotherapy and in Combination with Trametinib in Subjects with BRAF | Contract | * | Clinical Trial | Aparna Nallagangula | Cancer Center Division | C4 Therapeutics, Inc. | 06/2024 |
| A Phase 1a/1b Dose Escalation/Expansion Study of TTX-080, an HLA-G Antagonist, as Monotherapy and in Combination with Pembrolizumab or Cetuximab in Patients with Advanced Solid Refractory/Resistant Ma | Contract | * | Clinical Trial | Pavani Chalasani | Cancer Center Division | Tizona Therapeutics, Inc. | 06/2024 |
| A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Immune-Complex Membranoprolifera | Contract | * | Clinical Trial | Amy Sussman | Medicine | Apellis Pharmaceuticals | 06/2024 |
| A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation | Contract | * | Clinical Trial | Wilber Su | COM Phx Internal Medicine | Boston Scientific Corporation | 06/2024 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subject | Contract | * | Clinical Trial | Chian Kwoh | Medicine | Pharmaceutical Research Associates | 06/2024 |
| AdvanTIG-211: A Randomized, Double-blind, Placebo-controlled, Phase II Study Evaluating the Efficacy and Safety of Ociperlimab (WCD118) Combined With Tislelizumab (VDT482) Plus Chemotherapy Versus Pla | Contract | * | Clinical Trial | Sima Ehsani Chimeh | Cancer Center Division | Novartis Pharmaceutical Corporation | 06/2024 |
| Anchor Biorepository, Sample Shipping and Handling, and Datafile Generation | Contract | 310,995.00 | Other Sponsored Activity | Monika Schmelz | Pathology | National Cancer Institute | 06/2024 |
| Arizona Geriatrics Workforce Enhancement Program | Cooperative Agreement | 4,923,639.00 | Instruction | Mindy Fain | Arizona Center on Aging | Health Resources and Services Administration | 06/2024 |
| Arizona State Opioid Response - Support Overdose Fatality Review Program | Contract | 376,376.00 | Other Sponsored Activity | Daniel Brooks | COM Phx Ctr Tox&Pharm Ed&Res | Arizona Department of Health Services | 06/2024 |
| Building a Translational Workforce Innovation Network (TWIN) | Grant | 66,914.00 | Research | Taben Hale | COM Phx Basic Medical Sci | Colorado State University | 06/2024 |
| Conform Pivotal Study: An Evaluation of the Safety and Effectiveness of the Conformal Left Atrial Appendage Seal (CLAAS) for Left Atrial Appendage Occlusion} | Contract | * | Clinical Trial | Marvin Eng | COM Phx Internal Medicine | Conformal Medical, Inc. | 06/2024 |
| Controlled Gradient Release of Biologics: Enhanced Nerve Conduit for Long-Gap Injury Repair (STTR Subcontract) | Contract | 110,234.00 | Research | John Elfar | Orthopedic Surgery | Pioneer Neurotech Inc. | 06/2024 |
| COVID-19 Vaccination Border Region Partnership | Contract | 176,650.10 | Other Sponsored Activity | Sheila Soto | Public Hlth Prac & Trans Rsch | Arizona Department of Health Services | 06/2024 |
| Creatine Kinase in the Natural History of Asthma | Grant | 402,109.00 | Research | Stefano Guerra | Asthma/Airway Disease Rsch Ctr | National Institute of Allergy and Infectious Disease | 06/2024 |
| Delineating Host Response to Central Venous Catheter Associated Candida Albicans Biofilm Infections, and Development of Novel Therapeutics to Combat Drug Resistant Biofilms | Grant | 29,700.00 | Research | Abhijit Date | Pharmacology and Toxicology | Lundquist Institute for Biomedical Innovation | 06/2024 |
| Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears | Contract | * | Clinical Trial | Anup Shah | COM Phx Orthopedics | Arthrex, Incorporated | 06/2024 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.